Late Preterm Corticosteroids and Neonatal Hypoglycemia
Status:
Not yet recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
This is a prospective randomized controlled trial investigating the timing of betamethasone
administration in late preterm infants in relation to delivery and impact on neonatal
hypoglycemia. Previous data has shown that neonatal hypoglycemia is increased in late preterm
infants that were exposed to antenatal corticosteroids. The investigators hypothesize that
the timing of steroid administration may impact the development of neonatal hypoglycemia.